Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 8 Nov 2004 |
| Novozymes, current statement of shareholdings | 1 Nov 2004 |
| Novozymes, notification from major shareholder (section 29) from Fidelity Investments | 27 Oct 2004 |
| Novozymes, quarterly report Q3 2004 | 27 Oct 2004 |
| Novozymes, quarterly statement of shareholdings | 16 Sept 2004 |